Management of ascites in cirrhosis

被引:6
作者
Bataller, R [1 ]
Arroyo, V [1 ]
Gines, P [1 ]
机构
[1] UNIV BARCELONA,LIVER UNIT,HOSP CLIN & PROV,E-08036 BARCELONA,SPAIN
基金
美国国家卫生研究院;
关键词
ascites; cirrhosis; portal hypertension; renal failure;
D O I
10.1111/j.1440-1746.1997.tb00360.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Ascites is one of the earliest and most common complications of patients with cirrhosis. A typical circulatory dysfunction characterized by arterial vasodilation, high cardiac output and stimulation of vasoactive systems is commonly present in these patients and is associated with a poor prognosis. The treatment of ascites has been based on the combination of a low-sodium diet and the administration of diuretics. The reintroduction of paracentesis and the recent introduction of the transjugular intrahepatic portosystemic shunt (TIPS) are the most relevant innovations in the treatment of ascites during the past two decades, although controlled trials in large series of patients are needed to delineate whether TIPS is a safe and useful treatment for these patients.
引用
收藏
页码:723 / 733
页数:11
相关论文
共 90 条
[1]  
Abrams GA, 1996, AM J GASTROENTEROL, V91, P1363
[2]   PLASMA-RENIN ACTIVITY AND URINARY SODIUM-EXCRETION AS PROGNOSTIC INDICATORS IN NONAZOTEMIC CIRRHOSIS WITH ASCITES [J].
ARROYO, V ;
BOSCH, J ;
GAYABELTRAN, J ;
KRAVETZ, D ;
ESTRADA, L ;
RIVERA, F ;
RODES, J .
ANNALS OF INTERNAL MEDICINE, 1981, 94 (02) :198-201
[3]   Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [J].
Arroyo, V ;
Gines, P ;
Gerbes, AL ;
Dudley, FJ ;
Gentilini, P ;
Laffi, G ;
Reynolds, TB ;
RingLarsen, H ;
Scholmerich, J .
HEPATOLOGY, 1996, 23 (01) :164-176
[4]   ARTERIOLAR VASODILATION AND THE PATHOGENESIS OF THE HYPERDYNAMIC CIRCULATION AND RENAL SODIUM AND WATER-RETENTION IN CIRRHOSIS [J].
ARROYO, V ;
GINES, P .
GASTROENTEROLOGY, 1992, 102 (03) :1077-1079
[5]  
ARROYO V, 1992, GASTROENTEROL CLIN N, V21, P237
[6]  
Arroyo V, 1989, GASTROENTEROL INT, V2, P195
[7]  
BANARES R, 1989, GASTROENTEROL HEPATO, V12, P233
[8]  
BATALLER R, 1997, IN PRESS SEMIN LIVER
[9]   IMPORTANCE OF PLASMA-ALDOSTERONE CONCENTRATION ON THE NATRIURETIC EFFECT OF SPIRONOLACTONE IN PATIENTS WITH LIVER-CIRRHOSIS AND ASCITES [J].
BERNARDI, M ;
SERVADEI, D ;
TREVISANI, F ;
RUSTICALI, AG ;
GASBARRINI, G .
DIGESTION, 1985, 31 (04) :189-193
[10]  
BLEI AT, 1995, THERAPEUTICS HEPATOL, P81